Clinical trial NCT03690037 - References

Primary Total Hip Arthroplasty — Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty

Citation(s)

•   Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM
  Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011 Dec;93(12):1577-85. doi: 10.1302/0301-620X.93B12.26989. Review.
•   Blanié A, Bellamy L, Rhayem Y, Flaujac C, Samama CM, Fontenay M, Rosencher N
  Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thromb Res. 2013 Jan;131(1):e6-e11. doi: 10.1016/j.thromres.2012.11.006. Epub 2012 Nov 26.
•   CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S
  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14.
•   Dawson J, Fitzpatrick R, Frost S, Gundle R, McLardy-Smith P, Murray D
  Evidence for the validity of a patient-based instrument for assessment of outcome after revision hip replacement. J Bone Joint Surg Br. 2001 Nov;83(8):1125-9.
•   Ekbäck G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U
  Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000 Nov;91(5):1124-30.
•   Frisch NB, Wessell NM, Charters MA, Yu S, Jeffries JJ, Silverton CD
  Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty. 2014 Sep;29(9 Suppl):189-92. doi: 10.1016/j.arth.2014.03.048. Epub 2014 May 24.
•   Gibon E, Courpied JP, Hamadouche M
  Total joint replacement and blood loss: what is the best equation? Int Orthop. 2013 Apr;37(4):735-9. doi: 10.1007/s00264-013-1801-0. Epub 2013 Feb 6. Review.
•   Gross JB
  Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983 Mar;58(3):277-80.
•   He S, Johnsson H, Zabczyk M, Hultenby K, Cao H, Blombäck M
  A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor. Br J Haematol. 2013 Mar;160(6):806-16. doi: 10.1111/bjh.12189. Epub 2013 Jan 30.
•   Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K
  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001886. doi: 10.1002/14651858.CD001886.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001886.
•   Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K
  Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth. 1999 Oct;83(4):596-601.
•   Kim TK, Chang CB, Koh IJ
  Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1849-58. doi: 10.1007/s00167-013-2487-y. Epub 2013 Mar 31. Review.
•   Krebs V, Hozack WJ, Callaghan JJ, Bohannon Mason J, Mont M, Parvizi J
  Eliminating transfusion in primary joint arthroplasty-an achievable goal. J Arthroplasty. 2014 Aug;29(8):1511. doi: 10.1016/j.arth.2014.07.014.
•   Levine BR, Haughom BD, Belkin MN, Goldstein ZH
  Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2014 Sep;29(9 Suppl):186-8. doi: 10.1016/j.arth.2014.01.038. Epub 2014 May 27.
•   Melander B, Gliniecki G, Granstrand B, Hanshoff G
  Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. (A comparative study with epsilon-aminocaproic acid). Acta Pharmacol Toxicol (Copenh). 1965;22(4):340-52.
•   Miao K, Ni S, Zhou X, Xu N, Sun R, Zhuang C, Wang Y
  Hidden blood loss and its influential factors after total hip arthroplasty. J Orthop Surg Res. 2015 Mar 18;10:36. doi: 10.1186/s13018-015-0185-9.
•   Mitra B, Mazur S, Cameron PA, Bernard S, Burns B, Smith A, Rashford S, Fitzgerald M, Smith K, Gruen RL; PATCH-Trauma Study Investigators
  Tranexamic acid for trauma: filling the 'GAP' in evidence. Emerg Med Australas. 2014 Apr;26(2):194-7. doi: 10.1111/1742-6723.12172.
•   Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE
  Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br. 2007 Mar;89(3):306-9.
•   Nadler SB, Hidalgo JH, Bloch T
  Prediction of blood volume in normal human adults. Surgery. 1962 Feb;51(2):224-32.
•   Napier RJ, Spence D, Diamond O, O'Brien S, Walsh T, Beverland DE
  Modifiable factors delaying early discharge following primary joint arthroplasty. Eur J Orthop Surg Traumatol. 2013 Aug;23(6):665-9. doi: 10.1007/s00590-012-1053-5. Epub 2012 Jul 22.
•   Nilsson IM
  Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol). 1980;14:41-7. Review.
•   Nilsson L, Rybo G
  Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation. Acta Obstet Gynecol Scand. 1965;44(3):467-73.
•   OKAMOTO S, SATO S, TAKADA Y, OKAMOTO U
  AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO. Keio J Med. 1964 Dec;13:177-85.
•   Oremus K, Sostaric S, Trkulja V, Haspl M
  Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. 2014 Jan;54(1):31-41. doi: 10.1111/trf.12224. Epub 2013 Apr 25.
•   Pilbrant A, Schannong M, Vessman J
  Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20(1):65-72.
•   Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O
  Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg. 2003 Apr;96(4):923-928. doi: 10.1213/01.ANE.0000054001.37346.03.
•   Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG
  Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014 Aug 12;349:g4829. doi: 10.1136/bmj.g4829.
•   Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I
  The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010 Apr 16;11:40. doi: 10.1186/1745-6215-11-40.
•   Soni A, Saini R, Gulati A, Paul R, Bhatty S, Rajoli SR
  Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty. 2014 Aug;29(8):1525-7. doi: 10.1016/j.arth.2014.03.039. Epub 2014 Apr 5.
•   Sukeik M, Alshryda S, Haddad FS, Mason JM
  Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011 Jan;93(1):39-46. doi: 10.1302/0301-620X.93B1.24984. Review.
•   Tan J, Chen H, Liu Q, Chen C, Huang W
  A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 2013 Oct;184(2):880-7. doi: 10.1016/j.jss.2013.03.099. Epub 2013 Apr 25.
•   Weber CF, Görlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D
  Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol. 2011 Jan;28(1):57-62. doi: 10.1097/EJA.0b013e32834050ab.
•   Wishart N, Beaumont R, Young E, Mccormack V, Swanson M
  11th Annual Report- National Joint Registry. 2014;(December 2013).
•   Yamasaki S, Masuhara K, Fuji T
  Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop. 2004 Apr;28(2):69-73. Epub 2003 Oct 10.
•   Zhou XD, Tao LJ, Li J, Wu LD
  Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013 Jul;133(7):1017-27. doi: 10.1007/s00402-013-1761-2. Epub 2013 Apr 25.
•   Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B
  The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg. 2004 Dec;99(6):1679-1683. doi: 10.1213/01.ANE.0000136770.75805.19.

Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and Knee Arthroplasty.

Details for clinical trial NCT03690037